Correlation Between BioPlus Acquisition and Forbion European

Can any of the company-specific risk be diversified away by investing in both BioPlus Acquisition and Forbion European at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioPlus Acquisition and Forbion European into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioPlus Acquisition Corp and Forbion European Acquisition, you can compare the effects of market volatilities on BioPlus Acquisition and Forbion European and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioPlus Acquisition with a short position of Forbion European. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioPlus Acquisition and Forbion European.

Diversification Opportunities for BioPlus Acquisition and Forbion European

0.0

Correlation Coefficient

BioPlus Acquisition  Forbion European

Pay attention - limited upside

The 3 months correlation between BioPlus and Forbion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioPlus Acquisition Corp and Forbion European Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forbion European Acq and BioPlus Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioPlus Acquisition Corp are associated (or correlated) with Forbion European. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forbion European Acq has no effect on the direction of BioPlus Acquisition i.e., BioPlus Acquisition and Forbion European go up and down completely randomly.

Pair Corralation between BioPlus Acquisition and Forbion European

If you would invest  0.00  in Forbion European Acquisition on October 25, 2024 and sell it today you would earn a total of  0.00  from holding Forbion European Acquisition or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioPlus Acquisition Corp  vs.  Forbion European Acquisition

BioPlus Acquisition Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioPlus Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BioPlus Acquisition is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Forbion European Acq

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Forbion European Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Forbion European is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with BioPlus Acquisition and Forbion European

The main advantage of trading using opposite BioPlus Acquisition and Forbion European positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioPlus Acquisition position performs unexpectedly, Forbion European can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forbion European will offset losses from the drop in Forbion European's long position.

The idea behind BioPlus Acquisition Corp and Forbion European Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.